Stock Recommendations by Top Fund Houses

Leading brokerage firms have updated their ratings and target prices on several stocks. UBS maintains a buy on Thermax and Pidilite, raising targets to Rs 4100 and Rs 3600, respectively. GS also backs Pidilite with a Rs 3475 target. Jefferies supports Navin Fluorine at Rs 5280. MOSL upgrades Auro Pharma to buy at Rs 1360.

Dr Reddy sees mixed opinions—Nomura and Nuvama maintain a buy with targets at Rs 1575 and Rs 1533. However, BofA, Emkay, Citi, and JP Morgan have neutral views, with targets ranging from Rs 1050 to Rs 1450. ICICI and Antique downgrade targets, while Jefferies maintains underperformance at Rs 1010.

Swiggy’s outlook is neutral to negative, with MOSL, Citi, JP Morgan, and Macquarie cutting targets between Rs 260 and Rs 540. Biocon has a buy call from Citi at Rs 430. UBS maintains neutrality on ABB at Rs 5900. CLSA backs Manappuram with an outperform rating at Rs 260.

Bharti Airtel retains an overweight stance from Morgan Stanley at Rs 1870. These recommendations offer insights into fund houses’ latest perspectives on key stocks.